Related Experiment Video
Updated: May 25, 2026
03:59
Surgical Correction for Pediatric Epiblepharon and Trichiasis
Published on: July 8, 2025
Thermocautery for inferior conjunctivochalasis
Satoru Nakasato1, Riyo Uemoto, Nobuhisa Mizuki
1Department of Ophthalmology, Miura Municipal Hospital, Miura, Japan.
Cornea
|January 17, 2012
Summary
Thermocautery effectively treats symptomatic inferior conjunctivochalasis, a condition causing conjunctival laxity. This simple procedure resolved symptoms in over 92% of patients, offering a lasting solution.
Area of Science:
- Ophthalmology
- Surgical Techniques
Background:
- Inferior conjunctivochalasis is characterized by redundant conjunctival tissue, leading to discomfort and ocular surface issues.
- Topical medications are often the first-line treatment for symptomatic conjunctivochalasis.
Purpose of the Study:
- To detail a thermocautery technique for treating symptomatic inferior conjunctivochalasis.
- To evaluate the efficacy and outcomes of thermocautery in managing this condition.
Main Methods:
- A cohort of 23 patients (39 eyes) with symptomatic inferior conjunctivochalasis underwent thermocautery.
- Redundant conjunctival tissue was precisely excised using a low-temperature cauterizer after a positive ligation test.
- Follow-up assessments were conducted over a mean period of 469.5 days.
Main Results:
- Thermocautery led to symptom resolution in 92.3% (36/39 eyes) and improvement in 7.7% (3/39 eyes).
- Conjunctival laxity resolved in 92.3% of treated eyes and improved in 7.7%.
- No recurrences of conjunctival laxity were observed during the follow-up period.
Conclusions:
- Thermocautery presents a straightforward and highly effective therapeutic option for symptomatic inferior conjunctivochalasis.
- The procedure demonstrates a high success rate and durable results in managing conjunctival laxity.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...